Enter your login e-mail to the account
Search
Search parameters
Search results
- Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - ČLÁNKY UVEREJNENÉ V ČASOPISE VIA PRACTICA V ROKU 2007
(1/2008, attachment ) - The review of clinical and preclinical studies about the effects of Chlorella pyrenoidosa and young barley leaves on organism
doc. MUDr. Martin Péč, PhD., doc. MUDr. Renata Péčová, PhD., Doc. RNDr. Peter Kubatka, PhD.
(5/2015, Review articles ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Pharmacological therapy and non-pharmacological measures in patient after myocardial infarction
prof. MUDr. Peter Mitro, PhD.
(2/2011, Review articles ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - XIV. medzinárodné sympózium o ateroskleróze v Ríme
MUDr. Ľubomíra Fábryová
(9/2006, Events ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - CONGESTIVE HEART FAILURE TREATMENT
prof. MUDr. Viliam Bada, CSc.
(11/2007, Topic ) - Z jubilejného piateho ročníka kongresu Medicína pre prax (11. – 12. 9. 2009, Bratislava)
Magdaléna Žiaková, redaktorka
(10/2009, Events )
- Mechanism of effect of agomelatine – the innovative approach to the treatment of depression
doc. MUDr. Ján Pečeňák, CSc.
(6/2009, Drugs & drug classes )
- CONSTITUTIONAL DERMATITIS
MUDr. Renata Schmiedbergerová
(4/2005, Review articles )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly )
- Risks and side effects of treatment of psoriasis in selected groups of patients
PharmDr. Marcel Jusko, PhD.
(3/2016, Current pharmacotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic )